Ischemic Cardiac Outcomes in Patients with AF Treated with Vitamin K Antagonism or Factor Xa Inhibition: Results from the ROCKET AF Trial

Kenneth W. Mahaffey, Harvey D. White, Christopher C. Nessel, Shaun G. Goodman, Jonathan P. Piccini, Manesh R. Patel, John F. Paolini, Richard C. Becker, Jonathan L. Halperin, Werner Hacke, Daniel E. Singer, Graeme J. Hankey, Robert M. Califf, Keith A. Fox, Gunter Breithardt

    Research output: Contribution to journalAbstract/Meeting Abstract

    Original languageEnglish
    Number of pages2
    JournalCirculation
    Volume124
    Issue number21
    Publication statusPublished - 22 Nov 2011

    Cite this

    Mahaffey, K. W., White, H. D., Nessel, C. C., Goodman, S. G., Piccini, J. P., Patel, M. R., Paolini, J. F., Becker, R. C., Halperin, J. L., Hacke, W., Singer, D. E., Hankey, G. J., Califf, R. M., Fox, K. A., & Breithardt, G. (2011). Ischemic Cardiac Outcomes in Patients with AF Treated with Vitamin K Antagonism or Factor Xa Inhibition: Results from the ROCKET AF Trial. Circulation, 124(21).